Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724257 | SCV000229691 | uncertain significance | not provided | 2014-12-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000189925 | SCV000243590 | benign | not specified | 2014-06-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001082491 | SCV000262356 | benign | Tuberous sclerosis 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001021817 | SCV001183482 | likely benign | Hereditary cancer-predisposing syndrome | 2015-10-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV001082491 | SCV002039820 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001021817 | SCV002533498 | benign | Hereditary cancer-predisposing syndrome | 2020-10-06 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV003996568 | SCV004831993 | benign | Tuberous sclerosis syndrome | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004537450 | SCV004730005 | likely benign | TSC2-related disorder | 2019-04-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |